Release of the new NHMRC guidelines on PSA testing and the early management of test-detected prostate cancer.
The new NHMRC guidelines are released on PSA testing. Is this a retrograde development with regards to the treatment of prostate cancer and is it out of step with modern management of prostate cancer? Will we see an increase in numbers of people presenting with metastatic disease in the coming years.